These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 20163295)
1. Burden of schizophrenia in recently diagnosed patients: healthcare utilisation and cost perspective. Nicholl D; Akhras KS; Diels J; Schadrack J Curr Med Res Opin; 2010 Apr; 26(4):943-55. PubMed ID: 20163295 [TBL] [Abstract][Full Text] [Related]
2. Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database. Pelletier EM; Ogale S; Yu E; Brunetta P; Garg J Clin Ther; 2009 Nov; 31(11):2653-64. PubMed ID: 20110008 [TBL] [Abstract][Full Text] [Related]
3. Costs associated with attempted suicide among individuals with bipolar disorder. Stensland MD; Zhu B; Ascher-Svanum H; Ball DE J Ment Health Policy Econ; 2010 Jun; 13(2):87-92. PubMed ID: 20919595 [TBL] [Abstract][Full Text] [Related]
4. The economic burden of lung cancer and the associated costs of treatment failure in the United States. Kutikova L; Bowman L; Chang S; Long SR; Obasaju C; Crown WH Lung Cancer; 2005 Nov; 50(2):143-54. PubMed ID: 16112249 [TBL] [Abstract][Full Text] [Related]
5. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis. Pelletier EM; Shim B; Goodman S; Amonkar MM Breast Cancer Res Treat; 2008 Mar; 108(2):297-305. PubMed ID: 17577662 [TBL] [Abstract][Full Text] [Related]
6. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities. Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302 [TBL] [Abstract][Full Text] [Related]
7. Costs of gastrointestinal events after outpatient opioid treatment for non-cancer pain. Kwong WJ; Diels J; Kavanagh S Ann Pharmacother; 2010 Apr; 44(4):630-40. PubMed ID: 20197473 [TBL] [Abstract][Full Text] [Related]
8. Health care resource utilization and costs in a commercially insured population of patients with bipolar disorder type I and frequent psychiatric interventions. Bagalman E; Muser E; Choi JC; Durden E; Macfadden W; Haskins JT; Dirani R Clin Ther; 2011 Oct; 33(10):1381-1390.e4. PubMed ID: 22000656 [TBL] [Abstract][Full Text] [Related]
9. Healthcare utilization and costs of patients with rosacea in an insured population. Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697 [TBL] [Abstract][Full Text] [Related]
10. Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease. Maddux FW; Shetty S; del Aguila MA; Nelson MA; Murray BM Ann Pharmacother; 2007 Nov; 41(11):1761-9. PubMed ID: 17895328 [TBL] [Abstract][Full Text] [Related]
11. Cost of care for new versus recurrent acute coronary syndrome patients. Shetty S; Halpern R; McCollam PL J Med Econ; 2008; 11(1):81-99. PubMed ID: 19450112 [TBL] [Abstract][Full Text] [Related]
12. The burden of chronic low back pain with and without a neuropathic component: a healthcare resource use and cost analysis. Mehra M; Hill K; Nicholl D; Schadrack J J Med Econ; 2012; 15(2):245-52. PubMed ID: 22136441 [TBL] [Abstract][Full Text] [Related]
13. The effect of adjunctive mood stabilizers on antipsychotic utilization pattern and health resource utilization for Medicaid enrollees with schizophrenia. Chen H; Kennedy WK; Dorfman JH; Fincham JE; Reeves J; Martin BC Curr Med Res Opin; 2007 Jun; 23(6):1351-65. PubMed ID: 17559734 [TBL] [Abstract][Full Text] [Related]
14. Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Barsky AJ; Orav EJ; Bates DW Arch Gen Psychiatry; 2005 Aug; 62(8):903-10. PubMed ID: 16061768 [TBL] [Abstract][Full Text] [Related]
15. Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia. Loosbrock DL; Zhao Z; Johnstone BM; Morris LS J Ment Health Policy Econ; 2003 Jun; 6(2):67-75. PubMed ID: 14578539 [TBL] [Abstract][Full Text] [Related]
16. The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population. Menzin J; Boulanger L; Marton J; Guadagno L; Dastani H; Dirani R; Phillips A; Shah H Respir Med; 2008 Sep; 102(9):1248-56. PubMed ID: 18620852 [TBL] [Abstract][Full Text] [Related]
17. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults. Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388 [TBL] [Abstract][Full Text] [Related]